Human respiratory syncytial virus epidemiology and demographics

Human respiratory syncytial virus Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Human Respiratory Syncytial Virus from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Human respiratory syncytial virus epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Human respiratory syncytial virus epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Human respiratory syncytial virus epidemiology and demographics
CDC on Human respiratory syncytial virus epidemiology and demographics
Human respiratory syncytial virus epidemiology and demographics in the news
Blogs on Human respiratory syncytial virus epidemiology and demographics
Directions to Hospitals Treating Human respiratory syncytial virus
Risk calculators and risk factors for Human respiratory syncytial virus epidemiology and demographics

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Prevalence

In the United States, 60% of infants are infected during their first RSV season, and nearly all children will have been infected with the virus by 2-3 years of age.

Age

RSV causes respiratory tract infections in patients of all ages. It is the major cause of lower respiratory tract infection during infancy and childhood.

Mortality Rate

The overall crude mortality rate due to RVS (cause of death unspecified) in the United States was 7.8 per 100,000 individuals. A breakdown of the mortality rate by age group revealed that the rate was highest among individuals aged 65 years or older, at 46.8 per 100,000. The mortality rate was also elevated among those aged 50-64 years, at 11.8 per 100,000. In contrast, the mortality rate was lower among individuals aged 1-4 years, at 1.1 per 100,000, and even lower among those aged one year or less, at 2.7 per 100,000.